Blackstone Inc Rezolute, Inc. Transaction History
Blackstone Inc
- $22 Billion
- Q1 2025
A detailed history of Blackstone Inc transactions in Rezolute, Inc. stock. As of the latest transaction made, Blackstone Inc holds 1,744,740 shares of RZLT stock, worth $6.84 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,744,740
Previous 1,744,740
-0.0%
Holding current value
$6.84 Million
Previous $8.32 Million
39.21%
% of portfolio
0.02%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding RZLT
# of Institutions
82Shares Held
39.7MCall Options Held
402KPut Options Held
19.4K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$44.2 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$9.31 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.11MShares$8.28 Million1.66% of portfolio
-
Marshall Wace, LLP London, X01.85MShares$7.23 Million0.01% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.7MShares$6.66 Million0.55% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $152M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...